secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0001213900-23-053500
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity enters $350K secured note with 3i LP; amends preferred conversion price to $8.00
--------------------------------------------------------------------------------

- Issued $350,000 secured promissory note to 3i LP, maturing July 31, 2023, at 5% annual interest.
- Note secured by all company assets; proceeds for working capital and general corporate purposes.
- Filed Second Certificate of Amendment reducing Series A Preferred conversion price from $0.75 to $8.00, reflecting 1:40 reverse stock split.
- Outstanding obligations payable at next financing or convertible into 486 Series A Preferred shares if insufficient proceeds.
- 3i LP is the sole holder of Series A Preferred and has existing relationship with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023053500/0001213900-23-053500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023053500/ea181165-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-053500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer